PBMs Are Stacking the Deck Against Patients and Independent Physician Practices

MedPage Today) — I often hear my patients ask the same questions: Why do I need to change to another infusible biosimilar again? Why do I need to get my infusion therapy sent by a specialty pharmacy? Will I be able to continue my therapy on time…